Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Dermatology · Olmsted Syndrome

Managing Daily Care and Treatment Options

At a Glance

Olmsted syndrome has no current cure, so care focuses on lifelong skin softening, pain and itch control, and preventing movement or circulation problems. Treatment may include thick moisturizers, prescribed medicines, procedures, and carefully monitored experimental therapy.

Managing Olmsted syndrome is a lifelong process that requires dedication and a specialized medical team. Because the skin cells multiply rapidly, treatment focuses on thinning the excess skin, managing intense pain and itching, and preventing physical complications. It is important to know that there is currently no cure, and the benefits from most treatments are often partial and temporary—the skin plaques will begin to rebuild if maintenance is stopped [1][2].

The Foundation: Daily Skin Care

The cornerstone of management is a rigorous, daily skin-care regimen designed to soften hard plaques.

  • Emollients: Thick, greasy moisturizers (like petroleum-based ointments) are used several times a day to trap moisture in the skin [1].
  • Topical Keratolytics: These are “skin-thinning” agents that help break down the excess keratin. Common ingredients include urea, salicylic acid, and lactic acid [3].
    • Pediatric Safety Warning: A dermatologist must choose the exact product, concentration, area, and frequency. Salicylic acid applied over large areas or under occlusion in children can be absorbed systemically and cause severe toxicity. Keratolytics can burn fissured or inflamed skin and must never be applied near the eyes, mouth, or genital openings [1].
  • Mechanical Debridement: After the skin is softened, a medical professional or trained caregiver may gently remove layers of the thickened skin. Safety Warning: Never use sharp cutting tools or perform unsupervised mechanical debridement at home; your clinician must provide specific, safe instructions [2].

Systemic Medications

When topical creams are not enough, doctors may prescribe “systemic” medications—pills that work throughout the whole body.

  • Retinoids: Drugs like acitretin or isotretinoin (related to Vitamin A) can help slow down the rapid growth of skin cells [4]. Results are variable; some individuals see improvement in mobility, while others do not respond well [4][5].
    • Safety Box: Acitretin and isotretinoin are not interchangeable and require strict specialist supervision. They are highly teratogenic; strict reproductive counseling is essential for anyone who could become pregnant. They also require routine monitoring of liver tests, lipids, and bone health. Never start, stop, or share these medications without the prescribing team.
  • Pain and Itch Management: Because the pain and pruritus (itching) can be intense, specific medications (like antihistamines or nerve pain treatments) are often required to help improve sleep and function [1][6].

Emerging Targeted Therapies

In recent years, research has linked some Olmsted syndrome mutations to the over-activation of the EGFR pathway [6]. This has led to the investigational, off-label use of EGFR inhibitors like erlotinib.

Case reports and small series have described improvements in skin thickness and pain, with some patients regaining mobility [6][7]. However, this is an experimental treatment, and benefit is not guaranteed. Eligibility may depend on the specific genetic variant. It requires informed consent and strict specialist monitoring for potentially serious adverse effects, including liver toxicity, dehydration, severe skin reactions, drug interactions, and rare lung/ocular effects, not just rash and diarrhea [7].

Surgical Interventions

Surgery is generally reserved for complications that cannot be managed with medication alone, and it does not correct the underlying genetic disorder.

  • Contractures and Pseudoainhum: If the skin becomes so tight that it “locks” a joint or cuts off circulation to a digit, prompt surgical release may be necessary [1][5]. If a constricting band threatens a digit, urgent surgical or vascular assessment is required to prevent irreversible tissue loss. Waiting for “auto-amputation” is never an acceptable pathway; amputation is a last-resort consequence of completely nonviable tissue [1].
  • Excision and Grafting: In rare, severe cases where the skin is resistant to all other treatments, doctors may surgically remove the thickened skin and replace it with a skin graft [8]. Outcomes are variable, and graft complications or recurrence of plaques can occur [9].

Treatment for Olmsted syndrome is a marathon, not a sprint. You may find that a treatment works well for a few months and then becomes less effective, or that you need to combine several different approaches. Staying in close contact with a multidisciplinary team is the best way to adapt care as symptoms change [10][11].

Common questions in this guide

What daily skin care is used for Olmsted syndrome?
Daily care usually combines thick moisturizers with a dermatologist-selected skin-thinning medicine, such as urea, salicylic acid, or lactic acid. Once plaques are softened, a clinician or trained caregiver may remove loosened skin safely. These measures control symptoms rather than cure the condition, and plaques may return when maintenance stops.
Can children use salicylic acid for Olmsted syndrome?
Children should use salicylic acid or other skin-thinning products only when a dermatologist has chosen the product, strength, areas, and schedule. Applying salicylic acid over large areas or under a covering can cause serious absorption and toxicity, and keratolytics can burn cracked or inflamed skin. They should not be applied near the eyes, mouth, or genital openings.
How can pain and itching from Olmsted syndrome be managed?
Pain and itching may need medicines in addition to skin-softening treatment. Clinicians may consider antihistamines for itch or medicines used for nerve pain, especially when symptoms disturb sleep or mobility. The treatment plan should be individualized by the care team.
Are acitretin and isotretinoin treatment options for Olmsted syndrome?
These prescription retinoids may slow rapid skin-cell growth, but results vary and they are not interchangeable. They require specialist supervision, regular liver, cholesterol and triglyceride, and bone-health monitoring, plus strict pregnancy-prevention counseling because they can seriously harm a developing fetus. Do not start, stop, or share either medicine without the prescribing team.
Is erlotinib a proven treatment for Olmsted syndrome?
Erlotinib is an investigational, off-label EGFR inhibitor that has helped some people in small reports, but it is not guaranteed to work. Whether it is considered may depend on the person's genetic variant. It requires informed consent and close specialist monitoring for problems such as liver injury, dehydration, severe skin reactions, drug interactions, and rare lung or eye effects.
When does Olmsted syndrome require urgent surgery?
Seek urgent surgical or vascular assessment if tight skin locks a joint, forms a constricting band around a finger or toe, or threatens blood flow. Prompt treatment may prevent irreversible tissue loss. Amputation is not a planned treatment for the condition and is considered only when tissue is completely nonviable.
Can Olmsted syndrome be cured?
There is currently no cure for Olmsted syndrome. Treatments can soften plaques, reduce pain and itching, and improve movement, but benefits are often partial or temporary. Ongoing follow-up with a multidisciplinary team helps adjust daily care as symptoms and treatment response change.

Get notified when new evidence is published on Mutilating palmoplantar keratoderma with periorificial keratotic plaques.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Olmsted syndrome: clinical, molecular and therapeutic aspects.

    Duchatelet S, Hovnanian A

    Orphanet journal of rare diseases 2015; (10()):33 doi:10.1186/s13023-015-0246-5.

    PMID: 25886873
  2. 2

    Olmsted Syndrome: Case Report of Nursing Management of Premature Twins.

    Anderson S, Paradise J, Esser M

    Advances in neonatal care : official journal of the National Association of Neonatal Nurses 2022; (22(4)):333-340 doi:10.1097/ANC.0000000000000942.

    PMID: 34596089
  3. 3

    Exploring alternative approaches: A case report on palmoplantar keratoderma treated with unani medicine.

    Ilyas DJ, Jamal DMA

    Explore (New York, N.Y.) 2025; (21(3)):103138 doi:10.1016/j.explore.2025.103138.

    PMID: 40073694
  4. 4

    Olmsted Syndrome in a 12-year-old Filipino Male: A Case Report and Future Directions.

    Pandapatan AT, Tan CJ, Tan JAS

    Acta medica Philippina 2024; (58(17)):83-87 doi:10.47895/amp.v58i17.7957.

    PMID: 39431258
  5. 5

    Olmsted Syndrome: Rare Occurrence in Four Siblings.

    Bukharia A, Komal S, Sudhanan VM, Chaudhary SS

    Indian journal of dermatology 2016; (61(3)):347 doi:10.4103/0019-5154.182467.

    PMID: 27293270
  6. 6

    Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.

    Greco C, Leclerc-Mercier S, Chaumon S, et al.

    JAMA dermatology 2020; (156(2)):191-195 doi:10.1001/jamadermatol.2019.4126.

    PMID: 31895432
  7. 7

    Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.

    Zhang A, Duchatelet S, Lakdawala N, et al.

    JAMA dermatology 2020; (156(2)):196-200 doi:10.1001/jamadermatol.2019.4141.

    PMID: 31895414
  8. 8

    Cutting Through Complexity: Surgical Management of Severe Palmoplantar Keratoderma.

    Khan MT, Amjad I, Khan MR

    Cureus 2024; (16(7)):e65768 doi:10.7759/cureus.65768.

    PMID: 39211646
  9. 9

    Collagen Matrix and Staged Skin Grafting for Plantar Reconstruction: Lessons Learned in Treatment of Palmoplantar Keratoderma.

    Choi J, Applebaum MA, Feldmann ME

    Eplasty 2024; (24()):e67.

    PMID: 40463924
  10. 10

    Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.

    Butala S, Phan S, Siegel DH, et al.

    Pediatric dermatology 2023; (40(4)):735-737 doi:10.1111/pde.15264.

    PMID: 36709954
  11. 11

    TRPV3 Mutation-Associated Olmsted Syndrome in a Hispanic Patient: Response to Erlotinib and Review of Literature.

    Arias-Berrios G, Ortiz-López LI, Sánchez-Flores X

    Pediatric dermatology 2025; (42(4)):835-840 doi:10.1111/pde.15892.

    PMID: 39910762

This page explains daily care and treatment options for Olmsted syndrome for informational purposes only and does not constitute medical advice. Use keratolytics, retinoids, or experimental therapies only under guidance from your dermatologist and specialist team.